CD86 and β2-adrenergic receptor stimulation regulate B-cell activity cooperatively

Trends in Immunology

Volumn 26, Issue 4, 2005, Pages 180-185

  Podojil, Joseph R ^a,b   Sanders, Virginia M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CD86 ANTIGEN; IMMUNOGLOBULIN G1; OCTAMER TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CD86 PROTEIN, HUMAN; CD86 PROTEIN, MOUSE; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

B LYMPHOCYTE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; B-LYMPHOCYTES; HUMANS; IMMUNOGLOBULIN G; MEMBRANE GLYCOPROTEINS; MICE; MODELS, IMMUNOLOGICAL; NEUROIMMUNOMODULATION; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 20044369425     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.02.005     Document Type: Article

References (50)

1. Hathcock, K.S. et al. (1993) Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262, 905-907
2. Lenschow, D.J. et al. (1993) Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. U. S. A. 90, 11054-11058
3. Salomon, B. and Bluestone, J.A. (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252
4. Kasprowicz, D.J. et al. (2000) Stimulation of the B cell receptor, CD86 (B7-2), and the β-2-adrenergic receptor intrinsically modulates the level of IgG1 produced per B cell. J. Immunol. 165, 680-690
5. Jeannin, P. et al. (1997) CD86 (B7-2) on human B cells: a functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells. J. Biol. Chem. 272, 15613-15619
6. Podojil, J.R. et al. (2004) CD86 and β2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B Expression and binding to the 3′-IgH enhancer in B cells. J. Biol. Chem. 279, 23394-23404
7. Suvas, S. et al. (2002) Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J. Biol. Chem. 277, 7766-7775
8. Podojil, J.R. and Sanders, V.M. (2003) Selective regulation of mature IgG1 transcription by CD86 and β2-adrenergic receptor stimulation. J. Immunol. 170, 5143-5151
9. Ader, R. et al. (1990) Interactions between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol. 30, 561-602
10. Besedovsky, H.O. and Del Rey, A. (1996) Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr. Rev. 17, 64-102
11. + T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53, 487-525
12. Steinman, L. (2004) Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5, 575-581
13. Felten, S.Y. and Felten, D.L. (1991) Innervation of lymphoid tissue. In Psychoneuroimmunology (2nd edn) (Ader, R. et al., eds), pp. 27-69, Academic Press
14. + Th2 cells in vivo increases norepinephrine release in the spleen and bone marrow. J. Immunol. 165, 725-733
15. Sanders, V.M. et al. (2001) Neurotransmitter receptors on lymphocytes and other lymphoid cells. In Psychoneuroimmunology (Vol. 2) (3rd edn) (Ader, R. et al., eds), pp. 161-196, Academic Press
16. Sanders, V.M. et al. (1997) Differential expression of the β-2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 158, 4200-4210
17. Kohm, A.P. and Sanders, V.M. (1999) Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J. Immunol. 162, 5299-5308
18. Kohm, A.P. et al. (2002) B cell receptor- and β2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J. Immunol. 168, 6314-6322
19. Roper, R.L. et al. (2002) Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1. Immunol. Lett. 84, 191-198
20. Galizzi, J.P. et al. (1988) IFN-γ and prostaglandin E2 inhibit IL-4-induced expression of Fcε R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor. J. Immunol. 141, 1982-1988
21. 2+ channel Cav1.2. Science 293, 98-101
22. Hathcock, K.S. and Hodes, R.J. (1996) Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses. Adv. Immunol. 62, 131-166
23. Tang, H. and Sharp, P.A. (1999) Transcriptional regulation of the murine 3′ IgH enhancer by OCT-2. Immunity 11, 517-526
24. Stevens, S. et al. (2000) Role of OCA-B in 3′-IgH enhancer function. J. Immunol. 164, 5306-5312
25. Zelazowski, P. et al. (2000) NF-κB/p50 and NF-κ/c-Rel differentially regulate the activity of the 3′αE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner. Int. Immunol. 12, 1167-1172
26. Bendall, H.H. et al. (1997) Transcription factor NF-κB regulates inducible Oct-2 gene expression in precursor B lymphocytes. J. Biol. Chem. 272, 28826-28828
27. D'Souza, B.N. et al. (2004) Nuclear factor κB-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J. Virol. 78, 1800-1816
28. Chen, C. et al. (2000) The Rel/NF-κB fmily directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20, 2687-2695
29. Caamano, J.H. et al. (1998) Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187, 185-196
30. Warren, W.D. et al. (1999) Regulation of the germline immunoglobulin Cγ1 promoter by CD40 ligand and IL-4: dual role for tandem NF-κB binding sites. Mol. Immunol. 36, 31-44
31. Wolf, I. et al. (1998) Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-κB directs expression of the homing receptor BLR1 to mature B cells. J. Biol. Chem. 273, 28831-28836
32. Gunn, M.D. et al. (1998) A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391, 799-803
33. Marsland, A.L. et al. (2002) Stress, immune reactivity and susceptibility to infectious disease. Physiol. Behav. 77, 711-716
34. Robbins, J.B. et al. (1995) Perspective hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171, 1387-1398
35. Fine, D.P. et al. (1988) Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3. J. Lab. Clin. Med. 112, 487-497
36. Goodnow, C.C. et al. (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682
37. Rathmell, J.C. et al. (1998) Repression of B7.2 on self-reactive B cell is essential to prevent proliferation and allow Fas-mediated deletion by CD4-positive T cells. J. Exp. Med. 188, 651-659
38. Alt, F.W. et al. (1992) VDJ recombination. Immunol. Today 13, 306-314
39. Diaz, M. and Casali, P. (2002) Somatic immunoglobulin hypermutation. Curr. Opin. Immunol. 14, 235-240
40. Warren, W.D. and Berton, M.T. (1995) Induction of germline γ-1 and ε Ig gene expression in murine B cells: IL-4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J. Immunol. 155, 5637-5646
41. Pinaud, E. et al. (2001) Localization of the 3′ IgH locus elements that effect long-distance regulation of class switching recombination. Immunity 15, 187-199
42. Khamlichi, A.A. et al. (2000) The 3′ IgH regulatory region: a complex structure in a search for a function. Adv. Immunol. 75, 317-345
43. Clerc, R.G. et al. (1988) The B-cell-specific Oct-2 protein contains POU box- and homeobox-type domains. Genes Dev. 2, 1570-1581
44. Corcoran, L.M. and Karvelas, M. (1994) Oct-2 is required in T cell-independent B cell activation for G1 progression and for proliferation. Immunity 1, 635-645
45. Humbert, P.O. and Corcoran, L.M. (1997) Oct-2 gene disruption eliminates the peritoneal B-1 lymphocytes linage and attenuates B-2 cell maturation and function. J. Immunol. 159, 5273-5285
46. Kim, U. et al. (1996) The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383, 542-547
47. Nielsen, P.J. et al. (1996) B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26, 3214-3218
48. Schubart, D.B. et al. (1996) B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 383, 538-542
49. Francis, D.A. et al. (1995) Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7, 151-161
50. Lang, P. et al. (2001) TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-α/β dimers. Science 291, 1537-1540